Cargando…

Correlations of CYP2C9∗3/CYP2D6∗10/CYP3A5∗3 gene polymorphisms with efficacy of etanercept treatment for patients with ankylosing spondylitis: A case–control study

BACKGROUND: The tumor necrosis factor alpha (TNF-α) inhibitor etanercept has been proven to be effective in the treatment of ankylosing spondylitis (AS), while genetic polymorphism may affect drug metabolism or drug receptor, resulting in interindividual variability in drug disposition and efficacy....

Descripción completa

Detalles Bibliográficos
Autor principal:	Chen, Yuan-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	6900
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340430/ https://www.ncbi.nlm.nih.gov/pubmed/28248857 http://dx.doi.org/10.1097/MD.0000000000005993

Ejemplares similares

Efficacy of needle-knife combined with etanercept treatment regarding disease activity and hip joint function in ankylosing spondylitis patients with hip joint involvement: A randomized controlled study
por: You, Yuquan, et al.
Publicado: (2020)

Protective effect of anthrax toxin receptor 2 polymorphism rs4333130 against the risk of ankylosing spondylitis
por: Xu, Haitao, et al.
Publicado: (2020)

The Role of MicroRNAS in Ankylosing Spondylitis
por: Li, Zheng, et al.
Publicado: (2016)

Influence of kyphosis in ankylosing spondylitis on cardiopulmonary functions
por: Yang, Yunfei, et al.
Publicado: (2023)

The LMP2 CfoI polymorphism is associated with ankylosing spondylitis (AS) risk but not with acute anterior uveitis (AAU): A meta-analysis
por: Qian, Yufeng, et al.
Publicado: (2019)

Identification of potential target genes for ankylosing spondylitis treatment
por: Ni, Yong, et al.
Publicado: (2018)

Risk factors of uveitis in ankylosing spondylitis: An observational study
por: Sun, Li, et al.
Publicado: (2016)

Combination Analysis in Genetic Polymorphisms of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese Population
por: Ota, Tomoko, et al.
Publicado: (2015)

The Effects of H(2)S on the Activities of CYP2B6, CYP2D6, CYP3A4, CYP2C19 and CYP2C9 in Vivo in Rat
por: Wang, Xianqin, et al.
Publicado: (2013)

Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates
por: Saiz-Rodríguez, Miriam, et al.
Publicado: (2020)

Efficacy of warming needle moxibustion in the treatment of ankylosing spondylitis: A protocol of a randomized controlled trial
por: Ding, Weizhong, et al.
Publicado: (2021)

CYP3A and CYP2C19 activity in urine in relation to CYP3A4, CYP3A5, and CYP2C19 polymorphisms in Russian peptic ulcer patients taking omeprazole
por: Denisenko, Natalia P, et al.
Publicado: (2018)

Determining the relationship of kinesiophobia with respiratory functions and functional capacity in ankylosing spondylitis
por: Er, Göktuğ, et al.
Publicado: (2017)

Musculoskeletal ultrasound for ankylosing spondylitis: A systematic review and meta-analysis
por: Zhu, Lin, et al.
Publicado: (2021)

A case report of primary biliary cholangitis combined with ankylosing spondylitis
por: Hou, Chunfeng, et al.
Publicado: (2023)

Functional Measurement of CYP2C9 and CYP3A4 Allelic Polymorphism on Sildenafil Metabolism
por: Tang, Peng-fei, et al.
Publicado: (2020)

Prevalence of CYP2D6*2, CYP2D6*4, CYP2D6*10, and CYP3A5*3 in Thai breast cancer patients undergoing tamoxifen treatment
por: Charoenchokthavee, Wanaporn, et al.
Publicado: (2016)

The comparative efficacy of supervised- versus home-based exercise programs in patients with ankylosing spondylitis: A meta-analysis
por: Liang, Hui, et al.
Publicado: (2020)

Increase risk of allergic diseases in patients with ankylosing spondylitis: A 10-year follow-up population-based study in Taiwan
por: Chang, Wei-Pin, et al.
Publicado: (2016)

Influence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis
por: Wang, Yu, et al.
Publicado: (2017)

Cardiac Autonomic Function in Patients With Ankylosing Spondylitis: A Case-Control Study
por: Wei, Cheng-Yu, et al.
Publicado: (2016)

The bone mineral density of hip joint was reduced in the initial stage of ankylosing spondylitis?
por: Cai, Peng Li, et al.
Publicado: (2020)

The value of the sacroiliac joint area as a new morphological parameter of ankylosing spondylitis
por: Bang, Yun-Sic, et al.
Publicado: (2022)

Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort
por: Landi, Margarita, et al.
Publicado: (2016)

A Robust and Fast/Multiplex Pharmacogenetics Assay to Simultaneously Analyze 17 Clinically Relevant Genetic Polymorphisms in CYP3A4, CYP3A5, CYP1A2, CYP2C9, CYP2C19, CYP2D6, ABCB1, and VKORC1 Genes
por: Tron, Camille, et al.
Publicado: (2022)

Comparison of Paeoniflorin and Albiflorin on Human CYP3A4 and CYP2D6
por: Gao, Li-Na, et al.
Publicado: (2015)

CYP3A4, CYP2C9 and CYP2B6 expression and ifosfamide turnover in breast cancer tissue microsomes
por: Schmidt, R, et al.
Publicado: (2004)

Cementless total hip arthroplasty in patients with ankylosing spondylitis: A retrospective observational study
por: Xu, Jun, et al.
Publicado: (2017)

Ankylosing spondylitis complicating Turner syndrome: Two case reports and a literature review
por: Chen, Fang-Fei, et al.
Publicado: (2020)

Rheumatoid arthritis coexisting with ankylosing spondylitis: A report of 22 cases with delayed diagnosis
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population
por: Kudzi, William, et al.
Publicado: (2009)

Polymorphisms in the cytochrome P450 genes CYP1A2, CYP1B1, CYP3A4, CYP3A5, CYP11A1, CYP17A1, CYP19A1 and colorectal cancer risk
por: Bethke, Lara, et al.
Publicado: (2007)

Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity
por: Rodríguez-Morató, Jose, et al.
Publicado: (2019)

Relationship between serum adipokine levels and radiographic progression in patients with ankylosing spondylitis: A preliminary 2-year longitudinal study
por: Park, Ji-Heh, et al.
Publicado: (2017)

Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes
por: Lee, Jin Sol, et al.
Publicado: (2013)

Progression rate of ankylosing spondylitis in patients with undifferentiated spondyloarthritis: A systematic review and meta-analysis
por: Xia, Qing, et al.
Publicado: (2017)

The association between ankylosing spondylitis and the risk of any, hip, or vertebral fracture: A meta-analysis
por: Zhang, Min, et al.
Publicado: (2017)

Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis
por: Ma, Zeren, et al.
Publicado: (2017)

Association of sleep disturbance with calcitonin, disease severity and health index among patients with ankylosing spondylitis
por: Chen, Chun-Hsiung, et al.
Publicado: (2021)

TCM nonpharmacological interventions for ankylosing spondylitis: A protocol for systematic review and network meta-analysis
por: Wang, Haiyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ookmootc529brepgej7n4m1pm